Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeiSchemaViewiSchemaView Launches RAPID U

iSchemaView Launches RAPID U

New learning system and certification program sets international standard for professional status as a RAPID imaging practitioner. Empowers multiple members of stroke care teams to quickly become proficient

The company has launched RAPID U, a training certification program for iSchemaView’s RAPID technology. An imaging standard around the world, RAPID is the platform designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke.

Powered by a mobile-first learning management system, RAPID U provides role-based learning paths for various members of stroke care teams, including imaging technologists, stroke coordinators, neuroradiologists, neurologists and neurointerventionalists. The program is resource-rich for a robust education. It is enhanced with videos, case studies, publications, and clinical trials information across 15 courses, which cover all aspects of RAPID modules and products, and is supplemented with live sessions.

“All aspects of the RAPID U certification program were developed by RAPID clinical and technology experts. It is unique, in that stroke care teams will be able to learn advanced imaging from the experts,” said Dr. Greg Albers, professor of Neurology at Stanford University, director of the Stanford Stroke Center and cofounder of iSchemaView. “iSchemaView is very excited to offer free RAPID certification to all customers via this new learning platform. As the availability of advanced stroke imaging continues to expand, it is vital for hospitals to have skilled individuals on their stroke care teams. RAPID U will help ensure that stroke care team members are fully trained on how to use RAPID effectively, and have a positive impact on patient outcomes.”

RAPID U is accessible from the desktop and mobile apps. This allows the stroke team to take courses and obtain certificates at their own pace, when and where they choose. Clinicians can become RAPID certified following the successful completion of each course, and can have the option to continue on to more advanced courses.

“Moving forward, RAPID U will provide increased visibility into clinical team readiness,” said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “This will allow an understanding of which modules are of particular interest, and move on to more advanced training as needed. Most importantly, this educational program will enable more members of the stroke care team to optimize RAPID in reducing the debilitating impacts of stroke.”

Developed by leading stroke experts, RAPID technology has been selected for use in several groundbreaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app or corporate partner workflow systems.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy